G. Islander

发表

Severe neuroexcitatory symptoms after anaesthesia – with focus on propofol anaesthesia

E. Vinge, G. Islander, 2000, Acta anaesthesiologica Scandinavica.

A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermia

G. Islander, T. Fagerlund, E. R. Twetman, 1995, Clinical genetics.

Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers

E. Stålberg, H. Kalimo, N. Dahl, 2010, Muscle & nerve.

Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System

M. Pirmohamed, C. Palmer, S. Marshall, 2014, Clinical pharmacology and therapeutics.

Several interacting genes influence the malignant hyperthermia phenotype

K. Jurkat-Rott, A. Carsana, R. Robinson, 2003, Human Genetics.

Screening of the Ryanodine 1 Gene for Malignant Hyperthermia Causative Mutations by High Resolution Melt Curve Analysis

S. Treves, Kai Heinecke, M. Bodelsson, 2011, Anesthesia and analgesia.

Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH)

A. Bjorksten, G. Dranitsaris, N. Voermans, 2021, Neuromuscular Disorders.

Malignant hyperthermia and central core disease causative mutations in Swedish patients

G. Islander, M. Broman, C. Müller, 2007, Acta anaesthesiologica Scandinavica.

Results of in vitro contracture tests for the diagnosis of malignant hyperthermia susceptibility in monozygote twins

G. Islander, E. R. Twetman, 1997, Acta anaesthesiologica Scandinavica.

Silent Gastropharyngeal Regurgitation during Anesthesia

C. Carlsson, G. Islander, 1981, Anesthesia and analgesia.

Anesthesia and spinal muscle atrophy

G. Islander, 2013, Paediatric anaesthesia.

Evaluation of anaesthesias in malignant hyperthermia negative patients

G. Islander, E. Ranklev-Twetman, 1995, Acta anaesthesiologica Scandinavica.

Between-Center Variability of Results of the In Vitro Contracture Test for Malignant Hyperthermia Susceptibility

H. Ørding, G. Islander, D. Bendixen, 2000, Anesthesia and analgesia.

Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.

G. Islander, E. R. Twetman, 1999, Anesthesia and analgesia.

Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility

G. Islander, D. Bendixen, H. Örding, 2002, Acta anaesthesiologica Scandinavica.

Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands

H. Ørding, G. Islander, D. Bendixen, 1996, Acta anaesthesiologica Scandinavica.

A family with discordance between malignant hyperthermia susceptibility and rippling muscle disease

A. Smits, A. Melberg, J. Sundblom, 2013, Journal of Anesthesia.

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment

C. Wadelius, N. Eriksson, A. Syvänen, 2020, The Pharmacogenomics Journal.

Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation

H. Ørding, G. Islander, T. Fagerlund, 1997, Clinical genetics.

Next‐generation DNA sequencing of a Swedish malignant hyperthermia cohort

S. Rost, C R Müller, S Rost, 2015, Clinical genetics.

Male preponderance of patients testing positive for malignant hyperthermia susceptibility

M. Bodelsson, G. Islander, E. Ranklev, 2007, Acta anaesthesiologica Scandinavica.

Malignant hyperthermia susceptibility, an autosomal dominant disorder?

G. Islander, T. Fagerlund, E. R. Twetman, 1997, Clinical genetics.

Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle

G. Islander, T. Fagerlund, K. Barg, 1992, Clinical genetics.

Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosed

K. Henriksson, G. Islander, E. Ranklev-Twetman, 1995, Neuromuscular Disorders.

Streptococcal types in impetigo and acute glomerulonephritis among children in Addis Ababa.

S. Holm, G. Islander, L. Freij, 1976, Scandinavian journal of infectious diseases.

Functional Properties of RYR1 Mutations Identified in Swedish Patients with Malignant Hyperthermia and Central Core Disease

S. Treves, M. Bodelsson, G. Islander, 2010, Anesthesia and analgesia.

RYR1 mutation screening 1992 – 2014: a genetic report on 22 years from the Würzburg MH unit

M. Anetseder, G. Islander, F. Schuster, 2014, BMC Anesthesiology.

Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers

G. Islander, T. Fagerlund, K. Berg, 1996, Clinical genetics.

Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases.

A. Gehrig, M. Bodelsson, G. Islander, 2009, British journal of anaesthesia.

Dantrolene in the treatment of malignant hyperthermia: a case report

G. Islander, 2014, BMC Anesthesiology.

Malignant hyperthermia, a Scandinavian update

G. Islander, M. Broman, C. Müller, 2015, Acta anaesthesiologica Scandinavica.

CLINICAL RESEARCH O.6 Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia

A. Bjorksten, G. Dranitsaris, N. Voermans, 2021, Neuromuscular Disorders.

Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema and Cough

P. Hallberg, M. Wadelius, Hans-Erik Johansson, 2017, The Annals of pharmacotherapy.

Genome-Wide Association Study of Angioedema Induced by Ace Inhibitors or Arbs in Sweden

N. Eriksson, P. Magnusson, P. Hallberg, 2017 .